Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a medical device company focused on fully implantable hearing solutions, including the Acclaim Fully Implantable Cochlear Implant. The company entered the public markets through a de-SPAC merger with Anzu Special Acquisition Corp I, a blank-check vehicle sponsored by Anzu Partners LLC that completed its IPO in 2021. Envoy Medical operates in the healthcare and medical technology sector, developing implantable devices targeting patients with moderate-to-severe sensorineural hearing loss. Its Form 10-Q, filed May 16, 2022 under accession number 0001104659-22-061413, reflects the company's status as a publicly traded entity navigating early post-merger commercialization. Sign up at SpacDesk for full filings, transaction data, and ongoing coverage of Envoy Medical and the broader SPAC universe.